Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
2021 · Cancer Cell International · 139 citations
https://doi.org/10.1186/s12935-021-01792-4
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
965
Citations
15
h-index
22
i10-index
Yanan Peng is an academic researcher from First Affiliated Hospital of Shihezi University Medical College. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Cancer Immunotherapy and Biomarkers & Cancer, Lipids, and Metabolism. The author has an h-index of 15, co-authored 41 publications.
ORCID: 0000-0002-7439-1978Papers by this author
worksdmPFC-vlPAG projection neurons contribute to pain threshold maintenance and antianxiety behaviors
2020 · Journal of Clinical Investigation · 123 citations
https://doi.org/10.1172/jci127607
Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts
2014 · Biochemical and Biophysical Research Communications · 42 citations
https://doi.org/10.1016/j.bbrc.2014.07.074
SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer
2023 · BMC Gastroenterology · 40 citations
https://doi.org/10.1186/s12876-022-02621-2
A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates
2021 · Cell Reports Medicine · 17 citations
https://doi.org/10.1016/j.xcrm.2021.100448
Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer
2024 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-024-55048-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat